Main Menu

Our Work

Testimony on reasonable royalty to license patent for EpiPen

Randy Heeb testified at a bench trial on behalf of Seedlings Life Science Ventures, LLC in litigation against Pfizer. The case involved Pfizer’s alleged patent infringement in its use of the EpiPen, its product for treating severe allergic reactions. Dr. Heeb testified regarding the reasonable royalty that Pfizer would have paid Seedlings to license the relevant patent, based on a model of a hypothetical negotiation between the parties.

Jump to Page

We use cookies to optimize the performance of this site and give you the best user experience. By clicking "Accept," you agree to our use of cookies.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.